Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in Anticoagulation

Hirsh, 1991, Oral anticoagulant drugs, N Engl J Med, 324, 1865, 10.1056/NEJM199106273242606 Federatie van Nederlandse Trombosediensten. Samenvatting medische jaarverslagen. 2012. Available from: http://www.fnt.nl/media/docs/jaarverslagen/FNT_Medisch_jaarverslag_2012_WEB.pdf. [Accessed April 9, 2014]. Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Colilla, 2013, Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population, Am J Cardiol, 112, 1142, 10.1016/j.amjcard.2013.05.063 Heeringa, 2006, Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J, 27, 949, 10.1093/eurheartj/ehi825 Greenblatt, 2005, Interaction of warfarin with drugs, natural substances, and foods, J Clin Pharmacol, 45, 127, 10.1177/0091270004271404 Hirsh, 2001, Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest J, 119, 8S, 10.1378/chest.119.1_suppl.8S Fang, 2004, National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation, Arch Intern Med, 164, 55, 10.1001/archinte.164.1.55 De Schryver, 2005, Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke, J Neurol, 252, 1316, 10.1007/s00415-005-0858-0 Hylek, 2007, Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation, Circulation, 115, 2689, 10.1161/CIRCULATIONAHA.106.653048 Samsa, 2000, Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities, Arch Intern Med, 160, 967, 10.1001/archinte.160.7.967 Boulanger, 2006, Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non‐valvular atrial fibrillation in clinical practice, Int J Clin Pract, 60, 258, 10.1111/j.1368-5031.2006.00790.x Garcia-Alamino, 2010, Self-monitoring and self-management of oral anticoagulation, Cochrane Database Syst Rev, CD003839 Heneghan, 2012, Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data, Lancet, 379, 322, 10.1016/S0140-6736(11)61294-4 Horstkotte, 1998, Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease, J Thromb Thrombolysis, 5, 19, 10.1023/A:1013228718768 Connock, 2007, Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling, Health Technol Assess, 11, 10.3310/hta11380 Mauskopf, 2007, Principles of good practice for budget impact analysis: report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis, Value Health, 10, 336, 10.1111/j.1524-4733.2007.00187.x Sullivan, 2014, Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force, Value Health, 17, 5, 10.1016/j.jval.2013.08.2291 Menéndez-Jándula, 2005, Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial, Ann Intern Med, 142, 1, 10.7326/0003-4819-142-1-200501040-00006 Fitzmaurice, 2005, Self management of oral anticoagulation: randomised trial, BMJ, 331, 1057, 10.1136/bmj.38618.580903.AE Matchar, 2010, Effect of home testing of international normalized ratio on clinical events, N Engl J Med, 363, 1608, 10.1056/NEJMoa1002617 Siebenhofer, 2008, Self-management of oral anticoagulation reduces major outcomes in the elderly: a randomized controlled trial, Thromb Haemost, 100, 1089, 10.1160/TH08-06-0361 2008 Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package, J Stat Softw, 36, 1, 10.18637/jss.v036.i03 Den Haag/Heerlen. Central Institute of Statistics web site. Available from: http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37530NED&D1=0-1&D2=1-100&D3=0&D4=l&HDR=G1,G2&STB=G3,T&VW=T. [Accessed January 9, 2013]. DataMarket. HICP for health for the Netherlands. Available from: http://datamarket.com/data/set/18qu/hicp-2005-100-annual-data-average-index-and-rate-of-change#!ds=18qu!mh6=2:mh7=m:6ggm=s&display=table. [Accessed January 11, 2013]. Baeten, 2010, Lifetime health effects and medical costs of integrated stroke services—a non-randomized controlled cluster-trial based life table approach, Cost Eff Resour Alloc, 8, 21, 10.1186/1478-7547-8-21 Greving, 2011, Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis, BMJ, 342, 10.1136/bmj.d1672 Ten Cate‐Hoek, 2009, Cost‐effectiveness of ruling out deep venous thrombosis in primary care versus care as usual, J Thromb Haemost, 7, 2042, 10.1111/j.1538-7836.2009.03627.x Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Roos, 2002, Direct costs of modern treatment of aneurysmal subarachnoid hemorrhage in the first year after diagnosis, Stroke, 33, 1595, 10.1161/01.STR.0000016401.49688.2F Hakkaart-van Roijen, 2010, Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg, Geactualiseerde versie Nederlandse Zorgautoriteit (NZa). Bijlage 1 bij tariefbeschikking TB/CU-7078-01. Available from: http://www.nza.nl/. [Accessed November 18, 2014]. Regier, 2006, Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy, CMAJ, 174, 1847, 10.1503/cmaj.051104 Lafata, 2000, Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: a cost-effectiveness analysis, J Thromb Thrombolysis, 9, 13, 10.1023/A:1018704318655 Jowett, 2006, Patient self‐management of anticoagulation therapy: a trial‐based cost‐effectiveness analysis, Br J Haematol, 134, 632, 10.1111/j.1365-2141.2006.06243.x Evans, 2003, Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions, J Clin Nurs, 12, 77, 10.1046/j.1365-2702.2003.00662.x Ho, 2008, Evaluating the evidence: is there a rigid hierarchy?, Circulation, 118, 1675, 10.1161/CIRCULATIONAHA.107.721357 Nederlandse Vereniging voor Cardiologie. Leidraad begeleide introductie nieuwe orale antistollingsmiddelen. Available from: https://www.nvvc.nl/richtlijnen/bestaande-richtlijnen. [Accessed September 13, 2013]. Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Europace, 14, 1385, 10.1093/europace/eus305